Literature DB >> 15144133

Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice.

N Bizzaro1, A Wiik.   

Abstract

As a result of rapid changes in laboratory technology, clinical behaviour and patients' expectations, along with limited economic resources, there is a greater requirement for an appropriate use of autoantibody testing. We examine the various aspects and the most controversial points of the diagnostic procedure in systemic autoimmune rheumatic diseases, and make recommendations for the most efficient approach to autoantibody testing, based on selected publications and the relevant literature. Appropriateness is a complex task that can be achieved only by combining the efforts from the laboratory and the clinic, thereby using scientific knowledge, inter-disciplinary consultation and expert clinical investigation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15144133

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  20 in total

1.  A proposed model for effective collaboration between rheumatologists and clinical pathologists for the diagnosis of autoimmune rheumatic diseases.

Authors:  Nicola Bizzaro; Gabriella Morozzi
Journal:  Rheumatol Int       Date:  2008-11-22       Impact factor: 2.631

Review 2.  Autoimmune diagnostics: the technology, the strategy and the clinical governance.

Authors:  Nicola Bizzaro; Renato Tozzoli; Danilo Villalta
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

3.  An evaluation of autoimmune antibody testing patterns in a Canadian health region and an evaluation of a laboratory algorithm aimed at reducing unnecessary testing.

Authors:  Ada Man; Kam Shojania; Carmen Phoon; Jason Pal; Monika Hudoba de Badyn; David Pi; Diane Lacaille
Journal:  Clin Rheumatol       Date:  2013-01-06       Impact factor: 2.980

4.  Comparative study of immunofluorescent antinuclear antibody test and line immunoassay detecting 15 specific autoantibodies in patients with systemic rheumatic disease.

Authors:  Sun Ah Lee; Jimin Kahng; Yonggoo Kim; Yeon-Joon Park; Kyungja Han; Seung-Ki Kwok; Sung-Hwan Park; Eun-Jee Oh
Journal:  J Clin Lab Anal       Date:  2012-07       Impact factor: 2.352

Review 5.  Challenges in the Standardization of Autoantibody Testing: a Comprehensive Review.

Authors:  Renato Tozzoli; Danilo Villalta; Nicola Bizzaro
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

Review 6.  [Laboratory diagnostics for early detection of rheumatic autoimmune diseases: a guide for the general practitioner].

Authors:  Georg Endler; Ulrike Demel; Ernst Forster; Andrea Griesmacher; Christin Hübner; Werner Klotz; Günter Steiner; W Wagner; Manfred Herold
Journal:  Wien Med Wochenschr       Date:  2012-08-14

Review 7.  [Diagnostic strategies for autoimmune rheumatic diseases].

Authors:  A S Wiik
Journal:  Z Rheumatol       Date:  2007-05       Impact factor: 1.372

8.  How to report the antinuclear antibodies (anti-cell antibodies) test on HEp-2 cells: guidelines from the ICAP initiative.

Authors:  Carlos Alberto von Mühlen; Ignacio Garcia-De La Torre; Maria Infantino; Jan Damoiseaux; Luis E C Andrade; Orlando Gabriel Carballo; Karsten Conrad; Paulo Luiz Carvalho Francescantonio; Marvin J Fritzler; Manfred Herold; Werner Klotz; Wilson de Melo Cruvinel; Tsuneyo Mimori; Minoru Satoh; Lucile Musset; Edward K L Chan
Journal:  Immunol Res       Date:  2021-10-09       Impact factor: 2.829

Review 9.  Missing links in high quality diagnostics of inflammatory systemic rheumatic diseases: It is all about the patient!

Authors:  Allan S Wiik; Nicola Bizzaro
Journal:  Auto Immun Highlights       Date:  2012-04-11

Review 10.  Serology of Lupus Erythematosus: Correlation between Immunopathological Features and Clinical Aspects.

Authors:  Emanuele Cozzani; Massimo Drosera; Giulia Gasparini; Aurora Parodi
Journal:  Autoimmune Dis       Date:  2014-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.